In line with recent developments in the GST registration process, applicants must adhere to the following steps as per Rule 8 ...
GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. GSK does not need a miracle cure — just some rest and rehabilitation. Investors, though, seem unwilling ...
The pharmaceutical company said promising pipeline developments and high demand for drugs in its specialty segment lifted ...
The pharmaceutical company citied promising pipeline developments and said cancer treatments drove above-expected growth.
Pharmaceutical giant GlaxoSmithKline (GSK) has lifted its long-term sales guidance as it hailed a strong drug pipeline.